Patient-Friendly Explanation
Phendimetrazine is a prescription appetite suppressant used for short-term weight loss. It helps you feel less hungry by affecting certain brain chemicals. Like other older weight loss medications, it is only meant to be used for a few weeks as part of a broader plan that includes dietary changes and increased physical activity.
Clinical Definition
Phendimetrazine is a Schedule III-controlled sympathomimetic amine prodrug that is metabolised to phenmetrazine, which acts as a norepinephrine-dopamine releasing agent. It is FDA-approved for short-term obesity management (up to 12 weeks) as an adjunct to caloric restriction. Phendimetrazine produces an average placebo-subtracted weight loss of approximately 3 to 5 kilogrammes, with side effects including tachycardia, elevated blood pressure, insomnia, and dry mouth. It is contraindicated in patients with cardiovascular disease or uncontrolled hypertension.
Why It Matters
Phendimetrazine remains a viable option in the obesity pharmacotherapy toolkit, particularly for patients seeking a lower-cost short-term treatment. At NuLifeCare Singapore, we consider all FDA-approved medications — old and new — to create personalised treatment plans that balance efficacy, safety, tolerability, and affordability for each patient’s unique situation.